NDC11 00054037425
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00054-0374-25 | 00054-0374 |
| 00054-374-25 | 00054-374 |
| 0054-0374-25 | 0054-0374 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE | Hikma Pharmaceuticals USA Inc. | 6740a621-9bec-4178-a4fc-a3fc89f34e0a | 2026-04-25 | Boxed warning, Warnings, Adverse reactions | 0054-0374-25 0054-0374 00054037425 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.